Key Lessons from COVID-19: A Narrative Review Describing Qatar’s Multifactorial Approach in Executing a Vaccination Campaign
Open Access
Abstract
Widespread vaccination programs have been implemented in many countries to curtail the COVID-19 pandemic, with varying success and challenges. To better understand the successes and challenges of the global COVID-19 response in the face of emerging new variants and epidemiologic data, we discuss how Qatar engaged the healthcare sector, governmental bodies, and the populace to combat COVID-19, with a focus on the country’s vaccination strategy. This narrative provides the history and timeline of the Qatar COVID-19 vaccination campaign; factors that helped the vaccination campaign and the transferable lessons learned are discussed. Details regarding how Qatar responded to challenges, such as vaccine hesitancy and mitigation of misinformation, are highlighted. Qatar was one of the first countries to procure the BNT162b2 (Comirnaty®; Pfizer-BioNTech, Pfizer Inc., New York, NY, USA) and mRNA-1273 (Spikevax®; Moderna, Cambridge, MA, USA) COVID-19 vaccines. A relatively high vaccination rate and low case mortality rate (0.14% as of 4 January 2023) was observed in Qatar compared with other countries (global case mortality rate, 1.02%). Learnings will be carried forward as a basis for addressing this evolving pandemic and any future national emergencies in Qatar.Keywords
Funding Information
- Pfizer Gulf FZ LLC
This publication has 50 references indexed in Scilit:
- COVID‐19 vaccine hesitancy and attitudes in Qatar: A national cross‐sectional survey of a migrant‐majority populationInfluenza and Other Respiratory Viruses, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Laboring to communicate: Use of migrant languages in COVID-19 awareness campaign in QatarMultilingua, 2020
- Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February–18 April 2020BMJ Open, 2020
- Innovation Lessons From the COVID-19 PandemicMayo Clinic Proceedings, 2020
- Mitigating the wider health effects of covid-19 pandemic responseBMJ, 2020
- Vaccination coverage in Qatar: Benchmarking with global figuresQatar Medical Journal, 2019
- Vaccine hesitancy: understanding better to address betterIsrael Journal of Health Policy Research, 2016
- Vaccine hesitancy: Definition, scope and determinantsVaccine, 2015